Affymetrix Selects Singapore For Its First Manufacturing Facility Outside The United States
Affymetrix Inc. officially opened its manufacturing facility in Singapore. The new state-of-the-art building is Affymetrix's first manufacturing facility outside of the United States of America, enabling the company to better serve and support its growing international business.
"While Singapore offers a number of significant economic, political and lifestyle advantages, Affymetrix was most impressed with the country's commitment and support to the life sciences industry. In fact, a number of our most innovative and highly valued customers are here in Singapore, doing research in everything from cancer to population genetics to diabetes," said Mr Kevin King, president of life sciences business and executive vice president, Affymetrix. "This new facility enables us to better serve and support our growing customer base around the world."
The Singapore facility is located at the Keppel Logistics Building at Gul Circle, Jurong Industrial Park. It has been operational since the end of 2006 and employs 120 staff members. It was designed to look and operate like Affymetrix's main manufacturing facility in West Sacramento. By the end of 2007, Affymetrix plans to shift approximately 40 percent of its total microarray production to Singapore.
Most read news
Organizations
Other news from the department manufacturing

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

New Start-up develops aquafarms for macroalgae - AWI and Carbonwave spin-off: Large algae simultaneously bind CO₂ and create raw materials for the chemical industry

Sepsis in Children: Improved Diagnosis Thanks to New Global Criteria - Researchers applied machine-learning methods to extrapolate from the data analysis evidence-based criteria for diagnosing
Prostate Cancer Survival Rates Improved Since Introduction of PSA Testing - Survival Rate for African American Men Now Comparable to Caucasians, The Journal of Urology Reports

Selvita appoints Dr. Nicolas D. Beuzen as Chief Scientific Officer and Member of the Management Board
